Don’t miss the latest developments in business and finance.

Sun Pharma launches CEQUA in Canada

Image
Capital Market
Last Updated : Jan 27 2022 | 1:17 PM IST

Used to treat dry eye disease

Sun Pharma Canada Inc., a wholly owned subsidiary of Sun Pharmaceuticals Industries, announced the launch of CEQUA, a new treatment for Canadians living with dry eye disease. CEQUA (cyclosporine ophthalmic solution 0.09% w/v), a calcineurin inhibitor immunomodulator, is the first dry eye treatment available in Canada that is delivered with nanomicellar (NCELL) technology, which improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Jan 27 2022 | 12:43 PM IST

Next Story